Endonovo Therapeutics, Inc. (ENDV)

CIK 1528172 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Endonovo Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 19, 2024SEC STAFF ACTION9999999997-24-003881
Feb 2, 202415-12G0001493152-24-004800
Jan 3, 20248-K0001493152-24-000339
Dec 29, 202310-Q/A0001493152-23-046561
Dec 29, 202310-Q0001493152-23-046444
Dec 4, 20238-K0001493152-23-043516
Nov 15, 2023NT 10-Q0001493152-23-041435
Oct 12, 20238-K0001493152-23-036971
Aug 25, 20231-A/A0001493152-23-030138
Aug 21, 202310-Q0001493152-23-029706
Aug 15, 2023NT 10-Q0001493152-23-028695
Jun 14, 20231-A/A0001493152-23-021216
May 22, 202310-Q0001493152-23-018538
May 16, 2023NT 10-Q0001493152-23-017582
Apr 17, 202310-K0001493152-23-012553
Mar 31, 2023NT 10-K0001493152-23-010206
Mar 29, 20238-K0001493152-23-009376
Nov 21, 202210-Q0001493152-22-033118
Nov 14, 2022NT 10-Q0001493152-22-031710
Sep 27, 20228-K0001493152-22-026882
Aug 22, 202210-Q0001493152-22-023661
Aug 15, 2022NT 10-Q0001493152-22-022631
May 19, 202210-Q0001493152-22-014380
May 16, 2022NT 10-Q0001493152-22-013535
May 10, 20221-A/A0001493152-22-012733